Stock listing

Corvus Pharmaceuticals, Inc.

Selected listing: C17 · TRADEGATE · EUR · DE

Corvus Pharmaceuticals, Inc. (Tradegate:C17), Health Technology. Latest release Sep 30, 2026: Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical…

C17:TRADEGATEEURDEUpdated October 9, 2026
Corvus Pharmaceuticals, Inc. logo
Ticker
Tradegate:C17
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Tradegate
Currency
EUR

About Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. (Ticker: CRVS) is a publicly traded company based in the United States, focusing on the development of innovative therapies for cancer treatment. The company is committed to addressing unmet medical needs through its unique approach to drug development.

Latest news from Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa

September 30, 2026

Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference

September 3, 2026

Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial

August 27, 2026

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

August 6, 2026

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026

July 30, 2026

All Corvus Pharmaceuticals, Inc. news →

Events

Replays

  • Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 04:30 PM ET

    Watch

  • Corvus Pharmaceuticals, Inc. (CRVS) Q4 2025 Earnings Call

    Thu, Mar 12, 2026 · 04:30 PM ET

    Watch

  • Corvus Pharmaceuticals, Inc. (CRVS) Q3 2025 Earnings Call

    Tue, Nov 04, 2025 · 04:30 PM ET

    Watch

Research Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. company profile

View the public company page for Corvus Pharmaceuticals, Inc. on 6ix.

Corvus Pharmaceuticals, Inc. news

Read company news and market updates connected to Corvus Pharmaceuticals, Inc..

Corvus Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Corvus Pharmaceuticals, Inc..

Alternate listings

CRVS:NASDAQ

US · USD

Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:TRADEGATE.

C17:GETTEX

DE · EUR

Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:TRADEGATE.

A2AFXS:LSX

DE · EUR

Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:TRADEGATE.

A2AFXS:LS

DE · EUR

Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:TRADEGATE.

CRVS:BOATS

US · USD

Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:TRADEGATE.

C17:DUS

DE · EUR

Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:TRADEGATE.

C17:FWB

DE · EUR

Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:TRADEGATE.

C17:HAM

DE · EUR

Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:TRADEGATE.

C17:MUN

DE · EUR

Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:TRADEGATE.

C17:BX

CH · CHF

Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:TRADEGATE.

C17:SWB

DE · EUR

Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:TRADEGATE.